Atrium Health Wake Forest Baptist
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, United States52 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07214779 | |
| Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening | Colorectal Cancer Screening | Active, not recruiting | Not applicable | 2026-10-09 | NCT06821009 | |
| HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, erythropoietic protoporphyria, hepatic porphyria, hereditary disease, hereditary skin disorder, liver disorder, metabolic disease, porphyria, skin disorder | Enrolling by invitation | Phase 2 / Phase 3 | 2026-10-09 | NCT05883748 | |
| Wearable Robotics to Overcome Exercise Dose Limitations in Older Adults - Study 2 | Mobility Disability | Not yet recruiting | Not applicable | 2026-10-06 | NCT07859605 | |
| ID-ENTITY Trial- Evaluating Serial T-ID Monitoring | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, urinary system disorder | Enrolling by invitation | Not stated | 2026-10-06 | NCT07393594 | |
| Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2 | Aging; Multimorbidity; Palliative Care; Preventive Care | Recruiting | Not applicable | 2026-10-06 | NCT07166861 | |
| Wearable Robotics to Overcome Exercise Dose Limitations in Older Adults - Study 1 | Mobility Disability | Not yet recruiting | Not applicable | 2026-10-05 | NCT07857902 | |
| Pelashield vs Xeroform | Skin Graft | Recruiting | Phase 4 | 2026-10-01 | NCT07734519 | |
| Mindfulness in Nonflaccid Facial Paralysis | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, Synkinesis, facial paralysis, mouth disorder, nervous system disorder, palsy | Not yet recruiting | Not applicable | 2026-09-30 | NCT07127016 | |
| A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-09-28 | NCT06973187 | |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-09-28 | NCT06943872 | |
| A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 3 | 2026-09-28 | NCT06742996 | |
| Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations | Health Care Utilization | Recruiting | Not applicable | 2026-09-28 | NCT06682520 | |
| Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, hematologic disorder, hereditary antithrombin deficiency, hereditary disease, inherited blood coagulation disorder, thrombophilia | Recruiting | Phase 3 | 2026-09-28 | NCT06096116 | |
| The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2026-09-25 | NCT07560826 | |
| Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-09-25 | NCT07217587 | |
| Supporting Health and Empowerment Through Contingency Management and Affect Regulation | HIV Risk | Not yet recruiting | Not applicable | 2026-09-24 | NCT07792161 | |
| Efficacy of Intravenous Oxytocin to Speed Recovery After THA | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Enrolling by invitation | Phase 2 | 2026-09-24 | NCT07430228 | |
| Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, kidney disorder, toxic shock syndrome, urinary system disorder | Not yet recruiting | Phase 4 | 2026-09-24 | NCT06746753 | |
| Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct | Contracted Bladder | Not yet recruiting | Phase 2 | 2026-09-24 | NCT05054790 | |
| Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome, primary myelofibrosis | Recruiting | Phase 1 / Phase 2 | 2026-09-23 | NCT05320198 | |
| Tube Size Randomized Trial During Emergency Tracheal Intubation | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure | Enrolling by invitation | Not applicable | 2026-09-09 | NCT06939361 | |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-09-09 | NCT05633654 | |
| Facilitating the Implementation of Population-wide Genomic Screening | Population Genomic Screening Implementation Best Practices | Not yet recruiting | Not stated | 2026-09-08 | NCT07806643 | |
| Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older | AIDS, Blood-Borne Infections, Frailty, Genital Diseases, HIV infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-08-27 | NCT05858034 |